LGALS3 and diabetes mellitus: More importantly, Gal‐3 deficiency or TD139 treatment attenuates cytokine‐triggered apoptosis of beta cells by modulating the mitochondrial apoptotic pathway, suggesting a pivotal role of endogenous Gal‐3 in mediating beta cell apoptosis in the inflammatory milieu associated with diabetes pathogenesis.6